| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 07/17/2013 | CN101415683B New compounds |
| 07/16/2013 | US8487009 1,2-diphenylethene derivatives for treatment of immune diseases |
| 07/16/2013 | US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 07/16/2013 | US8486996 Aroylfuranes and aroylthiophenes |
| 07/16/2013 | US8486950 Janus kinase inhibitor compounds and methods |
| 07/16/2013 | CA2705474C O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 07/11/2013 | WO2013103738A1 Napthalene acetic acid derivatives against hiv infection |
| 07/11/2013 | WO2013102826A1 N-aminosulfonyl benzamides |
| 07/11/2013 | US20130178633 Phenol derivatives and the pharmaceutical or cosmetic use thereof |
| 07/11/2013 | US20130178631 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 07/11/2013 | US20130178457 Cannabinoid receptor modulators |
| 07/10/2013 | EP2612852A1 Theramutein modulators |
| 07/10/2013 | EP2611779A1 CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR |
| 07/10/2013 | EP2611778A1 Guanidine compounds and compositions for the inhibition of nampt |
| 07/10/2013 | EP2611777A1 4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl]amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer |
| 07/10/2013 | EP2611772A1 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors |
| 07/10/2013 | EP2611771A1 New compounds, pharmaceutical compositions and uses thereof |
| 07/10/2013 | EP2611441A1 Bace inhibitors for use in the treatment of diabetes |
| 07/10/2013 | CN103201267A Ampk-activating heterocyclic compounds and methods for using the same |
| 07/10/2013 | CN103201265A Novel microbiocides |
| 07/10/2013 | CN103201260A Drug derivatives |
| 07/10/2013 | CN103201259A Ethynylphenylamidine compound or salt thereof, method for producing same, and fungicide for agricultural and horticultural use |
| 07/10/2013 | CN103200936A Novel n-hydroxy-benzamides for the treatment of cancer |
| 07/10/2013 | CN103194197A 3, 5-dibromo-salicylaldehyde-condensed 2-pyridine formhydrazide and application thereof |
| 07/10/2013 | CN103193826A Nanocluster, as well as preparation method and application thereof |
| 07/10/2013 | CN103193764A Water-soluble small molecule pyridinium photoelectric material and preparation method and application thereof |
| 07/10/2013 | CN103193728A Synthesis process of chiral ionic liquid with (R)-thiazolidinyl-2-thione-4-carboxylic acid as negative ion |
| 07/10/2013 | CN103193705A Synthesis method of 2-chloronicotinic acid and derivative thereof |
| 07/10/2013 | CN103193704A 2-hydroxy-4-amino-5-methylpyridine heterocyclic compound |
| 07/10/2013 | CN103193703A Purifying method of 2, 3-dichloropyridine |
| 07/10/2013 | CN103193702A Functionalization method for nitrogenous heterocyclic compound |
| 07/10/2013 | CN103193701A Functional ligand and preparation method thereof |
| 07/10/2013 | CN103193691A Sulfonamide compound and medicinal compositions thereof, and preparation methods and applications thereof |
| 07/10/2013 | CN103193568A Selective hydrogenation reduction method of fluorine-containing aromatic hydrocarbon derivative |
| 07/10/2013 | CN103193567A Method for controllable reduction of unsaturated organic compound from catalysis of formic acid by nanogold |
| 07/10/2013 | CN102079744B Deuterated achiral crizotinib and derivatives, preparation method and application thereof |
| 07/10/2013 | CN101903352B Substituted 3-hydroxypyridines and pharmaceutical compositions thereof |
| 07/10/2013 | CN101874800B Medicament for treating chronic interstitial nephritis |
| 07/10/2013 | CN101796028B Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 07/10/2013 | CN101130526B Aryl carbonyl derivatives as therapeutic agents |
| 07/09/2013 | US8481745 N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use therof |
| 07/09/2013 | US8481725 Cycloalkylcarbonylamino acid derivative and process for producing the same |
| 07/09/2013 | US8481597 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 07/09/2013 | US8481576 Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors |
| 07/09/2013 | US8481569 Iminopyridine derivatives and use thereof |
| 07/09/2013 | CA2722087C 4-dimethylaminobutyric acid derivatives |
| 07/09/2013 | CA2607576C Improved chemical identification of peroxide-based explosives |
| 07/09/2013 | CA2533698C Lanthanide complexes preparation and uses thereof |
| 07/09/2013 | CA2516407C Heteroarylcarbamoylbenzene derivatives |
| 07/04/2013 | WO2013102078A1 Methods of producing methyl 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylate |
| 07/04/2013 | WO2013098147A1 Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives |
| 07/04/2013 | WO2013097773A1 Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators |
| 07/04/2013 | WO2013097224A1 Fused tricyclic compounds as raf kinase inhibitors |
| 07/04/2013 | WO2013019561A8 Nuclear transport modulators and uses thereof |
| 07/04/2013 | US20130174286 In Vivo Gene Silencing By Chemically Modified and Stable siRNA |
| 07/04/2013 | US20130172620 Method for production of f-18 labeled amyloid beta ligands |
| 07/04/2013 | US20130172566 Methods of producing methyl 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylate |
| 07/04/2013 | US20130172565 Methods of forming 4-chloro-2-fluoro-3-substituted-phenylboronic acid pinacol esters and methods of using the same |
| 07/04/2013 | US20130172564 Phenol derivatives and pharmaceutical or cosmetic use thereof |
| 07/04/2013 | US20130172558 Naproxen-based chiral compounds and liquid crystal display applications |
| 07/04/2013 | US20130172551 Process for Preparing Carbamolypyridone Derivatives and Intermediates |
| 07/04/2013 | US20130172543 Method for oxidizing alcohols |
| 07/04/2013 | US20130172393 Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning |
| 07/04/2013 | US20130172363 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 07/04/2013 | US20130172310 Benzamides and related inhibitors of factor xa |
| 07/04/2013 | DE102009022830B4 Verbessertes Verfahren zum Herstellen von Diaminopyridinen An improved process for preparing diaminopyridines |
| 07/04/2013 | DE10148438B4 Elektrochrome Vorrichtung Electrochromic device |
| 07/04/2013 | CA2861202A1 Novel nicotinamide derivative or salt thereof |
| 07/04/2013 | CA2856347A1 Fused tricyclic compounds as raf kinase inhibitors |
| 07/03/2013 | EP2610246A1 Ethanamine compounds and methods of using the same |
| 07/03/2013 | EP2609081A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes |
| 07/03/2013 | EP2609072A1 Chalcone structure fluorescence dye for embryonic stem cell probe |
| 07/03/2013 | EP2608666A1 Phenylamidines having a high fungicidal activity and use thereof |
| 07/03/2013 | CN103189356A N-heteroaryl compounds |
| 07/03/2013 | CN103189355A Electron transport material and organic electroluminescence element using same |
| 07/03/2013 | CN103189061A 4- (methylaminophenoxy) pyrdin- 3 - yl - benzamide derivatives for treating cancer |
| 07/03/2013 | CN103183636A New method for synthesizing 2, 2'-Bipyridyl-4, 4'-dicarboxylic acid |
| 07/03/2013 | CN103183635A New process for synthetizing 3-(pyridin-2-ylamino) ethyl propionate |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN102382049B Method for synthesizing 2-ethoxycarbonylaminosulfonyl-N,N-dimethyl nicotinamide |
| 07/03/2013 | CN102241626B Synthesis process of flupirtine maleate |
| 07/03/2013 | CN101701024B Ruthenium complex, preparation method thereof and application thereof |
| 07/03/2013 | CN101678007B Gonadotropin-releasing hormone receptor antagonists and its pharmaceutical application |
| 07/02/2013 | US8476457 Indole, indazole and benzimidazole arylamides as P2X3 and P2X2/3 antagonists |
| 07/02/2013 | US8476448 Solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one |
| 07/02/2013 | US8476444 Base generator |
| 07/02/2013 | US8476434 Protein kinase modulators and method of use |
| 07/02/2013 | US8476306 Urokinase inhibitors, production and use thereof |
| 07/02/2013 | US8476286 Quinazoline derivatives which promote the release of parathyroid hormone |
| 07/02/2013 | US8476275 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor |
| 07/02/2013 | US8476269 Pyridine and pyrazine derivative for the treatment of CF |
| 07/02/2013 | US8476257 Viral polymerase inhibitors |
| 07/02/2013 | US8476207 Quaternary ammonium salt detergents for use in lubricating compositions |
| 07/02/2013 | US8476197 Aminopropenoates as fungicides |
| 07/02/2013 | US8475768 Paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (MRI) |
| 07/02/2013 | CA2724716C Process for preparation of .alpha.-hydroxycarboxylic acid amides |
| 07/02/2013 | CA2545112C Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 07/02/2013 | CA2535483C Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 06/27/2013 | WO2013096771A1 Non-systemic tgr5 agonists |
| 06/27/2013 | WO2013095060A1 6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis |